使用血管活性药物重症病人肠内营养实施的进展  

Progress in enteral nutrition implementation in critically ill patients receiving vasoactive medications

作　　者：张宏宇 江利冰[1] 王海龙 许永安[1] 王承妃 阮峰 齐文旗 左素敏 徐善祥[1] ZHANG Hong-yu;JIANG Li-bing;WANG Hai-long;XU Yong-an;WANG Cheng-fei;RUAN Feng;QI Wen-qi;ZUO Su-min;XU Shan-xiang(Department of Emergency Medicine,The Second Affiliated Hospital of Zhejiang University School of Medicine/Zhejiang Key Laboratory of Trauma,Burn,and Medical Rescue/Zhejiang Critical and Critical Care Clinical Medical Research Center,Hangzhou 310009,Zhejiang,China)

机构地区：[1]浙江大学医学院附属第二医院急诊医学科/全省严重烧创伤诊治与应急救援重点实验室/浙江省急危重症临床医学研究中心,浙江杭州310009

出　　处：《肠外与肠内营养》2024年第3期176-183,共8页Parenteral & Enteral Nutrition

基　　金：浙江省自然科学基金项目(LQ20H150006);浙江省医药卫生科技计划项目(2024ky092)。

摘　　要：营养治疗是重症病人管理的核心内容之一,肠内途径因其营养及非营养双重作用成为了营养治疗的首选方式。血管活性药物的使用使得这部分病人肠内营养的决策更具挑战性。本综述系统回顾了血管活性药物对重症病人胃肠道的病理生理学影响、目前肠内营养在此部分病人中应用的价值及安全性,总结了在此部分病人中实施肠内营养的最佳策略以供临床参考。Nutritional therapy is a core component of critically ill patient management,and the enteral route has become the preferred method due to its dual roles of nutrition and non-nutrition.The use of vasoactive medications makes enteral nutrition decisions more challenging for these patients.This review systematically examines the pathophysiological effects of vasoactive medications on gastrointestinal tract of critically ill patients,the current value and safety of enteral nutrition in this patient’s population,summarizes the optimal strategies for implementing enteral nutrition in these patients for clinical reference.

关 键 词：肠内营养 血管活性药物 重症病人 实施策略 

分 类 号：R459.3[医药卫生—治疗学]